Moreover, we had 2 patients (out of 129) on anti-IL17A (secukinumab) resulting in IBD diagnosis after increase in faecal CP at W24, counselling with gastroenterologists and colonoscopy. The gene discussed is IL17A; the disease is inflammatory bowel disease.